OR-X
LIVE

Serial Number

79365618

Owner

Schweizerischer Verein Balgrist

Attorney

SARAH ANNE KEEFE

Filing Date

Jan 12, 2023

Add to watchlist:

No watchlists yet
View on USPTO

OR-X Trademark

Serial Number: 79365618 • Registration: 7682909

OR-X is a trademark filed by Schweizerischer Verein Balgrist on January 12, 2023. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Schweizerischer Verein Balgrist (2 trademarks)

Forchstrasse 340

Entity Type: 99

Trademark Details

Filing Date

January 12, 2023

Registration Date

February 11, 2025

Published for Opposition

December 24, 2024

Goods & Services

Training and further training in the field of surgery, orthopaedics, neurosurgery, and related disciplines being anaesthesia, surgical team training, emergency surgery training; Classes and lectures in the field of surgery, orthopaedics, neurosurgery, and related disciplines being anaesthesia, surgical team training, emergency surgery training; Training concerning the use of surgical and medical apparatus and instruments; organization and conducting of scientific conferences, congresses, symposiums, colloquiums and seminars in the field of surgery, orthopaedics, neurosurgery and related surgical and orthopaedic disciplines

Printing products being printed matter, namely, newsletters, magazines, brochures in the field of surgery and orthopedics; Printed instructional and teaching material in the field of medicine, orthopedics and surgery

Medical and surgical services, in particular services with respect to orthopedics; professional medical and surgery consultancy in the field of medical technology, medical surgery and orthopedics

Scientific and technological services as well as research services, namely, scientific and medical research featuring the conduction of research and development of data collection and validation experiments including ex-vivo human and in-vivo animal experiments, provision of hardware and software solutions being consulting services in the fields of selection, implementation and use of computer hardware and software systems for others and design and development of computer hardware and software systems for collecting and interpreting surgical data, provision of design and development services for computer- and robot-assisted surgery equipment, provision of technologies supporting surgical training and research in the nature of design and development of computer hardware and software; Scientific research and development with respect to surgery, in particular scientific research and development of new augmented-reality, artificial-intelligence and robotics technologies; conducting of tests, in particular in the field of orthopedics, namely, research and development services to enhance existing surgical or orthopaedic products as well as product testing and validation; Preparation of scientific reports, namely, scientific and medical research and information services; Design and development of computer hardware and software

Scientific, research and teaching apparatus and instruments, namely, data processing apparatus for supporting the collection and processing of data from different surgical devices and visual and non-visual sensing technologies to be used in surgery; Downloadable software for surgical training and teaching, downloadable software for acquiring, streaming, and processing surgical data from multiple modalities, downloadable software for controlling and orchestrating surgical and robotic devices, downloadable software for modelling and employing surgical data on local servers or in the cloud, downloadable software for training of AI, namely, surgical robot models with surgical data, downloadable software for generating digital twins of surgeries; Downloadable electronic publications, namely, newsletters, magazines, brochures in the field of surgery and orthopedics

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Oct 9, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 12, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 27, 2025 FICS
FINAL DISPOSITION PROCESSED
Aug 26, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 11, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 11, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 11, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 24, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 24, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 18, 2024 NONP
EXPARTE APPEAL TERMINATED
Nov 27, 2024 EXPT
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 27, 2024 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 27, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 27, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 27, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 27, 2024 CNEA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Oct 23, 2024 ERFR
EX PARTE APPEAL-INSTITUTED
Oct 23, 2024 EXPI
JURISDICTION RESTORED TO EXAMINING ATTORNEY
Oct 23, 2024 JURT
EXPARTE APPEAL RECEIVED AT TTAB
Oct 23, 2024 EXAF
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Sep 8, 2024 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 21, 2024 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Aug 21, 2024 OPNR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 23, 2024 GNFN
FINAL REFUSAL E-MAILED
Apr 23, 2024 GNFR
FINAL REFUSAL WRITTEN
Apr 23, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2024 TROA
REFUSAL PROCESSED BY IB
Nov 13, 2023 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 24, 2023 RFCS
REFUSAL PROCESSED BY MPU
Oct 24, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 13, 2023 RFCR
NON-FINAL ACTION WRITTEN
Oct 12, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 10, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 31, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 27, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 23, 2023 REPR